Compounds > tolbutamide
Page last updated: 2024-08-16

tolbutamide and ono 1078

tolbutamide has been researched along with ono 1078 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Cha, IJ; Kim, MJ; Lee, SS; Lee, YM; Liu, KH; Shin, JG; Shon, JH; Yoon, YR1
Higashi, R; Matsumoto, I; Miyata, Y; Nakade, S; Nunoya, K; Ogawa, M; Sutoh, F; Yoneda, K1

Other Studies

3 other study(ies) available for tolbutamide and ono 1078

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes.
    Xenobiotica; the fate of foreign compounds in biological systems, 2004, Volume: 34, Issue:5

    Topics: Aryl Hydrocarbon Hydroxylases; Chromones; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Indoles; Kinetics; Leukotriene Antagonists; Microsomes, Liver; Phenylcarbamates; Sulfonamides; Tolbutamide; Tosyl Compounds

2004
In vitro metabolism and inhibitory effects of pranlukast in human liver microsomes.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:4

    Topics: Anti-Asthmatic Agents; Antibodies, Blocking; Antifungal Agents; Cell Line, Tumor; Chromones; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Ketoconazole; Leukotriene Antagonists; Microsomes, Liver; Midazolam; Oxygenases; Terfenadine; Tolbutamide

2009